Evidence map›Paper›PMID 31114638›Full record

ReviewWorld journal of hepatology2019

Endoscopic ultrasound guided liver biopsy for parenchymal liver disease.

Aun Raza Shah, Muhannad Al-Hanayneh, Monica Chowdhry, Mohammad Bilal, Shailendra Singh

Abstract readReview
In one paragraph

Review in World journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Article
  7. Endohepatology: The endoscopic armamentarium in the hand of the hepatologist.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Update on endoscopic ultrasound-guided liver biopsy.World journal of gastroenterology · 2022
    Review
  12. Review
  13. Review
  14. Biopsy or cytology for diagnosing hepatic focal lesions?Clinical and molecular hepatology · 2021
    Article
  15. Article
  16. Review
  17. The utility of liver biopsy in 2020.Current opinion in gastroenterology · 2020
    Review
  18. Endoscopic ultrasound guided liver biopsy: Recent evidence.World journal of gastrointestinal endoscopy · 2020
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aun Raza ShahDepartment of Internal Medicine, MetroHealth Medical Center, Cleveland, OH 44109, United States.
Muhannad Al-HanaynehDivision of Gastroenterology and Hepatology, the University of Texas Medical Branch, Galveston, TX 77555, United States.
Monica ChowdhryDivision of Gastroenterology, Department of Internal Medicine, West Virginia University, Charleston, WV 25304, United States.
Mohammad BilalDivision of Gastroenterology and Hepatology, the University of Texas Medical Branch, Galveston, TX 77555, United States.
Shailendra SinghDivision of Gastroenterology, Department of Internal Medicine, West Virginia University, Charleston, WV 25304, United States. shail121@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver biopsy plays an essential role in the diagnosis, evaluation and management of a vast proportion of liver diseases. Conventionally, percutaneous and trans-jugular approaches have been used to obtain liver biopsies. Endoscopic ultrasound guided liver biopsy (EUS-LB) has emerged as a safe and effective alternate in the past two decades. EUS-LB carries a role in evaluation of both benign and malignant diseases of the liver. It can offer higher resolution imaging of the liver and can detect smaller lesions than computed tomography scan of the abdomen or ultrasound scans with the option for doppler assistance to reduce complications. Current evidence demonstrates the superiority of EUS-LB for a targeted approach of focal lesion and there is also evidence of less sampling variability in heterogeneous parenchymal pathologies. These advantages combined with an improved safety profile had led to the rapid progress in the development of new techniques, equipment and procedures for EUS-LB. We provide a comprehensive review of EUS-LB for parenchymal liver disease.

Indexed as

Endoscopic ultrasoundEndoscopic ultrasound guided liver biopsyLiver biopsyLiver disease

Identifiers

PMID31114638
PMCPMC6504861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.